These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10405203)

  • 41. Advanced glycated end-products affect HIF-transcriptional activity in renal cells.
    Bondeva T; Heinzig J; Ruhe C; Wolf G
    Mol Endocrinol; 2013 Nov; 27(11):1918-33. PubMed ID: 24030251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmembrane signalling in human monocyte/mesangial cell co-cultures: role of cytosolic Ca(2+).
    Menè P; Festuccia F; Polci R; Pugliese F; Cinotti GA
    Nephrol Dial Transplant; 2002 Jan; 17(1):42-9. PubMed ID: 11773461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine stimulates Ca2+ fluxes and increases cytosolic free Ca2+ in cultured rat mesangial cells.
    Olivera A; López-Rivas A; López-Novoa JM
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):871-6. PubMed ID: 1554371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications.
    Bao W; Min D; Twigg SM; Shackel NA; Warner FJ; Yue DK; McLennan SV
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1212-9. PubMed ID: 20810913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.
    Throckmorton DC; Brogden AP; Min B; Rasmussen H; Kashgarian M
    Kidney Int; 1995 Jul; 48(1):111-7. PubMed ID: 7564067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.
    Ziyadeh FN; Cohen MP
    Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.
    McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA
    J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway.
    Wilmer WA; Dixon CL; Hebert C
    Kidney Int; 2001 Sep; 60(3):858-71. PubMed ID: 11532081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products.
    Xu D; Kyriakis JM
    J Biol Chem; 2003 Oct; 278(41):39349-55. PubMed ID: 12871951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells.
    Hua H; Munk S; Goldberg H; Fantus IG; Whiteside CI
    J Biol Chem; 2003 Sep; 278(36):33951-62. PubMed ID: 12821678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.
    Xiang G; Schinzel R; Simm A; Münch G; Sebekova K; Kasper M; Niwa T; Schmitz C; Heidland A
    Nephrol Dial Transplant; 2001 Aug; 16(8):1562-9. PubMed ID: 11477156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.
    Zhang Y; Lapidos KA; Gal-Moscovici A; Sprague SM; Ameer GA
    Artif Organs; 2014 Jun; 38(6):474-83. PubMed ID: 24206165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced glycation end-products accelerate telomere attrition and increase pro-inflammatory mediators in human WIL2-NS cells.
    Deo P; Dhillon VS; Lim WM; Jaunay EL; Donnellan L; Peake B; McCullough C; Fenech M
    Mutagenesis; 2020 Jul; 35(3):291-297. PubMed ID: 32319517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and transmembrane signaling of leukotriene D4 receptors in human mesangial cells.
    Simonson MS; Mené P; Dubyak GR; Dunn MJ
    Am J Physiol; 1988 Dec; 255(6 Pt 1):C771-80. PubMed ID: 2849305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.
    Vlassara H; Li YM; Imani F; Wojciechowicz D; Yang Z; Liu FT; Cerami A
    Mol Med; 1995 Sep; 1(6):634-46. PubMed ID: 8529130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms.
    Lim AI; Chan LY; Tang SC; Lai KN; Leung JC
    Inflamm Res; 2014 Oct; 63(10):831-9. PubMed ID: 25063374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative damage of vascular smooth muscle cells by the glycated protein-cupric ion system.
    Sakata N; Miyamoto K; Meng J; Tachikawa Y; Imanaga Y; Takebayashi S; Furukawa T
    Atherosclerosis; 1998 Feb; 136(2):263-74. PubMed ID: 9543097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
    Kaji Y; Amano S; Usui T; Oshika T; Yamashiro K; Ishida S; Suzuki K; Tanaka S; Adamis AP; Nagai R; Horiuchi S
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):521-8. PubMed ID: 12556378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.